Robotic Apparel to Prevent Freezing of Gait in Parkinson Disease
Part of paid clinical trials in Allston, Massachusetts.
- Sponsor
- Harvard Medical School (HMS and HSDM)
- Study ID
- NCT06602544
- Status
- Recruiting
Conditions
- Parkinson Disease (PD)
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - 90 Years
- Healthy Volunteers
- Not accepted
Interventions
- Robotic Apparel — DEVICEA robotic apparel system is a portable, lightweight textile-based wearable robot that is worn around the waist and thighs. The apparel provides assistive flexion moment about the hip joint during the swing phase of gait by spooling in a cable that connects the thigh wraps to the front of the waist belt. Inertial measurement units embedded in the thigh wraps are used to control the timing of the robotic apparel assistance. Robotic apparel assistance magnitude is delivered as a small percentage of the bodyweight of the wearer.
Study Details
Freezing-of-gait (FoG) in Parkinson Disease (PD) is one of the most vivid and disturbing gait phenomena in neurology. Often described by patients as a feeling of "feet getting glued to the floor," FoG is formally defined as a "brief, episodic absence or marked reduction of forward progression of the feet despite the intention to walk." This debilitating gait phenomena is very common in PD, occurring in up to 80% of individuals with severe PD. When FoG arrests walking, serious consequences can occur such as loss of balance, falls, injurious events, consequent fear of falling, and increased hospitalization. Wearable robots are capable of augmenting spatiotemporal gait mechanics and are emerging as viable solutions for locomotor assistance in various neurological populations. For the proposed study, our goal is to understand how low force mechanical assistance from soft robotic apparel can best mitigate gait decline preceding a freezing episode and subsequent onset of FoG by improving spatial (e.g. stride length) and temporal features (e.g. stride time variability) of walking. We hypothesize that the ongoing gait-preserving effects can essentially minimize the accumulation of motor errors that lead to FoG. Importantly, the autonomous assistance provided by the wearable robot circumvents the need for cognitive or attentional resources, thereby minimizing risks for overloading the cognitive systems -- a known trigger for FoG, thus enhancing the repeatability and robustness of FoG-preventing effects.
Key Dates
- Start date
- Sep 3, 2024
- Status verified
- Jul 2025
- Primary completion
- Sep 30, 2027
- Completion
- Sep 30, 2027
Study Design
- Enrollment
- 20 participants (estimated)
- Allocation
- NA
- Intervention model
- SINGLE_GROUP
- Primary purpose
- TREATMENT
Arms
- Experimental: Multi-visit ambulatory activities with soft robotic apparelParticipants will engage in ambulatory activities (i.e. straight-line walking, turning) with and without the assistance of robotic apparel, performed across multiple visits under various freezing-of-gait (FoG) provoking scenarios
Primary Outcome Measure
Change in percent time spent freezing [ Time Frame: Visit 4 (within 6 months after enrollment) ]
Central Contacts
- Franchino Porciuncula, EdD, PT, DScPT617-353-7525
- Teresa Baker, DPT617-353-7525
Locations (2)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Harvard Science and Engineering Complex | Allston | Massachusetts | 02134 | Conor J Walsh, PhD (PRINCIPAL_INVESTIGATOR) |
| Boston University Sargent College of Health and Rehabilitation Sciences | Boston | Massachusetts | 02215 | Terry Ellis, PhD, PT, FAPTA (PRINCIPAL_INVESTIGATOR) |
Find similar trials in Allston, MA
Related Studies
- GBPDC: Gut-Brain in PD Consortium Master ProtocolNot Yet Recruiting · Duke University · Stanford, California
- Safety, PK and Biodistribution of 18F-OP-801 in Patients With ALS, AD, MS, PD and Healthy VolunteersPHASE1/PHASE2 · Recruiting · Ashvattha Therapeutics, Inc. · San Francisco, California
- Behavioral Intervention for Lifestyle Physical Activity in Parkinson's DiseaseNot Yet Recruiting · University of Illinois at Chicago · Chicago, Illinois
- Pilot Trial Evaluating Patient Experience With the MemorEM for Patients With Neurological DiseasesEnrolling By Invitation · NeuroEM Therapeutics, Inc. · Tampa, Florida